6/4/2025China Approves First Homegrown 9-Valent HPV Vaccine

6/4/2025Sagimet and Ascletis Report Positive Phase 3 Results for Denifanstat i...

6/3/2025Leads Biolabs' LBL-024 Shows Promising Results in EP-NEC Treatment

6/3/2025Remegen, Junshi Report Strong DV Combo Data in HER2+ Gastric Cancer

6/3/2025CTTQ Achieves Breakthrough in Lung Cancer Treatment

6/3/2025Transcenta's Triple Therapy Shows Promising Results for G/GEJ

6/3/2025Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/2025OnCusp Unveils Promising Initial Results from First-in-Human Trial of ...

6/2/2025ArkBio's AK3280 Shows Significant Phase II Efficacy in IPF

5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine

5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/29/2025First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...

5/29/2025Rona Unveils Promising Preclinical Data for Annual RNAi Therapy

5/29/2025China Grants Conditional Approval to Hengrui's Famitinib

5/29/2025China Approves Zelgen's Gecacitinib

5/29/2025China Grants Conditional Approval to Two HER2-Targeted Therapies for A...

5/29/2025Kanion's Generic Sumatriptan/Naproxen Gains Approval in China

5/29/2025China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer

5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...

5/29/2025Kelun-Biotech Initiates Phase 1 Trial for SKB571, a Bispecific ADC Tar...

5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China

5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED

5/27/2025Hengrui's c-MET-Targeted ADC SHR-1826 Shows Promising Results in Phase...

5/27/2025Eisai's Dayvigo Receives Approval in China for Insomnia

Page:6/18 Total number of articles:534: [First][<<] [4] [5] [6] [7] [8] [>>] [End]